7-117610637-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000492.4(CFTR):c.3107C>T(p.Thr1036Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1036N) has been classified as Pathogenic.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CFTR | ENST00000003084.11 | c.3107C>T | p.Thr1036Ile | missense_variant | Exon 19 of 27 | 1 | NM_000492.4 | ENSP00000003084.6 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461332Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726960 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:4
ClinVar contains an entry for this variant (Variation ID: 618964). This missense change has been observed in individual(s) with cystic fibrosis (PMID: 17662673, 22892530, 24696795, 32442342). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1036 of the CFTR protein (p.Thr1036Ile). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CFTR protein function. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Thr1036 amino acid residue in CFTR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16189704, 27214204, 32429104; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. -
The p.T1036I variant (also known as c.3107C>T), located in coding exon 19 of the CFTR gene, results from a C to T substitution at nucleotide position 3107. The threonine at codon 1036 is replaced by isoleucine, an amino acid with similar properties. This variant has been identified in the homozygous state and/or in conjunction with other CFTR variant(s) in individual(s) who met clinical criteria for cystic fibrosis (Alibakhshi R, J. Cyst. Fibros. 2008 Mar; 7(2):102-9; Sahami A, J Reprod Infertil 2014 Jan; 15(1):49-56; Zybert K et al. Pediatr Pulmonol, 2020 Aug;55:2097-2107). Other variant(s) at the same codon, p.T1036N (c.3107C>A) have been identified in individual(s) with features consistent with cystic fibrosis (McGinniss MJ, Hum. Genet. 2005 Dec; 118(3-4):331-8). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Variant summary: CFTR c.3107C>T (p.Thr1036Ile) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250950 control chromosomes (gnomAD). c.3107C>T has been reported in the literature as a biallelic genotype in individuals affected with Cystic Fibrosis (e.g. Alibakhshi_2008, Sobczynska-Tomaszewska_2013, Zybert_2020) and in one heterozygous individual for which a second allele was not identified (Sahami_2014). A different variant affecting the same codon has been classified as pathogenic by our lab (c.3107C>A, p.Thr1036Asn), supporting the critical relevance of codon 1036 to CFTR protein function. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17662673, 22892530, 24696795, 32442342). ClinVar contains an entry for this variant (Variation ID: 618964). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
Cystic fibrosis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation Pathogenic:1
- -
Bronchiectasis with or without elevated sweat chloride 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at